Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer.

Subjects

Subjects :

Clinical Trials as Topic
Disease-Free Survival
Drug Design
Female
Humans
Ovarian Neoplasms mortality
Prognosis
Research Design
Treatment Outcome
Biomarkers, Tumor
CA-125 Antigen biosynthesis
Drug Evaluation
Ovarian Neoplasms drug therapy
Ovarian Neoplasms metabolism

Details

Language :

English

ISSN :

1078-0432

Volume :

10

Issue :

11

Database :

MEDLINE

Journal :

Clinical cancer research : an official journal of the American Association for Cancer Research

Publication Type :

Academic Journal

Accession number :

15173101

Full Text :

https://doi.org/10.1158/1078-0432.CCR-03-0787